Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.27 trillion and total revenue of $115.82 billion.
Market Cap
1.27T
Revenue
115.82B
Profits
-36.07B
PE Ratio
n/a
Profit Margin
-31.14%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 127.62B | -0.24% | 915,135 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 81.13B | 6.95% | 19,313,307 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 72.54B | -1.19% | 695,028 | 15.53B |
| 4 | ARGX | argenx SE | 56.95B | -0.69% | 322,128 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 44.51B | 0.50% | 1,424,725 | - |
| 6 | ONC | BeOne Medicines AG | 41.12B | 1.00% | 392,122 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 32.58B | -0.87% | 3,958,018 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.42B | 0.08% | 1,281,105 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.84B | 0.17% | 6,201,635 | 7.53M |
| 10 | BNTX | BioNTech SE | 24.53B | 0.76% | 1,437,531 | 3.03B |
| 11 | INCY | Incyte Corporation | 23.13B | -1.01% | 1,948,759 | 5.82B |
| 12 | INSM | Insmed Incorporated | 22.67B | -6.56% | 5,395,744 | 1.14B |
| 13 | GMAB | Genmab A/S | 21.31B | 10.73% | 12,403,391 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.32B | 0.16% | 844,580 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 14.98B | 0.07% | 783,227 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.58B | 0.79% | 2,580,702 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.78B | 3.07% | 5,277,705 | - |
| 18 | CORT | Corcept Therapeutics Incorporated | 13.19B | 4.99% | 1,004,939 | 830.81M |
| 19 | BBIO | BridgeBio Pharma, Inc. | 12.93B | -1.65% | 2,168,568 | 713.07M |
| 20 | TWST | Twist Bioscience Corporation | 12.86B | 8.66% | 3,207,966 | 431.80M |
| 21 | HALO | Halozyme Therapeutics, Inc. | 12.29B | -1.41% | 1,856,187 | 1.66B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.40B | -1.16% | 246,484 | 1.28B |
| 23 | TECH | Bio-Techne Corporation | 11.38B | 0.25% | 2,087,229 | 1.22B |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 11.14B | 0.63% | 2,407,511 | 3.41B |
| 25 | IBRX | ImmunityBio, Inc. | 11.00B | 0.92% | 16,866,948 | 165.79M |
| 26 | PCVX | Vaxcyte, Inc. | 10.98B | 30.70% | 14,924,050 | - |
| 27 | KRYS | Krystal Biotech, Inc. | 9.91B | 3.90% | 337,046 | 440.48M |
| 28 | AXSM | Axsome Therapeutics, Inc. | 9.28B | -1.21% | 858,894 | 776.57M |
| 29 | KYMR | Kymera Therapeutics, Inc. | 9.13B | 2.29% | 729,726 | 105.00M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 9.10B | 0.41% | 1,273,823 | 281.99M |
| 31 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.81B | -2.87% | 2,249,456 | 669.50M |
| 32 | CYTK | Cytokinetics, Incorporated | 8.72B | -4.42% | 3,234,412 | 67.67M |
| 33 | CAI | Caris Life Sciences, Inc. | 8.59B | 7.39% | 4,959,323 | 989.61M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 8.18B | -0.50% | 642,857 | - |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 7.92B | -4.04% | 511,236 | 7.46M |
| 36 | ABVX | ABIVAX Société Anonyme | 7.91B | -1.24% | 840,305 | 5.33M |
| 37 | TGTX | TG Therapeutics, Inc. | 7.65B | -0.70% | 1,546,886 | 799.54M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.23B | -0.09% | 2,871,833 | 874.09M |
| 39 | IMVT | Immunovant, Inc. | 6.87B | -1.10% | 1,104,070 | - |
| 40 | BLTE | Belite Bio, Inc | 6.41B | -0.24% | 133,266 | - |
| 41 | IOVA | Iovance Biotherapeutics, Inc. | 6.41B | -0.49% | 11,751,492 | 324.97M |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.37B | -0.41% | 1,027,247 | 239.92M |
| 43 | LGND | Ligand Pharmaceuticals Incorporated | 6.12B | 1.26% | 163,820 | 290.54M |
| 44 | CGON | CG Oncology, Inc. | 6.09B | 1.97% | 788,354 | 6.23M |
| 45 | KOD | Kodiak Sciences Inc. | 5.88B | -0.68% | 3,235,663 | - |
| 46 | ORKA | Oruka Therapeutics, Inc. | 5.59B | -0.17% | 629,593 | - |
| 47 | CRSP | CRISPR Therapeutics AG | 5.54B | 3.45% | 1,703,095 | 13.39M |
| 48 | TVTX | Travere Therapeutics, Inc. | 5.44B | 1.30% | 2,643,947 | 591.33M |
| 49 | COGT | Cogent Biosciences, Inc. | 5.36B | -0.48% | 1,792,883 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.31B | 0.30% | 1,044,026 | 1.01B |
| 51 | MIRM | Mirum Pharmaceuticals, Inc. | 5.29B | -1.81% | 980,144 | 618.07M |
| 52 | SRRK | Scholar Rock Holding Corporation | 5.29B | -7.28% | 3,352,006 | - |
| 53 | ERAS | Erasca, Inc. | 5.15B | -0.14% | 5,486,349 | - |
| 54 | MANE | Veradermics, Incorporated | 4.97B | 1.81% | 536,363 | - |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.92B | -0.19% | 597,421 | 1.90M |
| 56 | DFTX | Definium Therapeutics, Inc. | 4.87B | -3.13% | 2,602,204 | - |
| 57 | ABCL | AbCellera Biologics Inc. | 4.47B | 0.29% | 4,075,088 | 66.17M |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.38B | -2.66% | 1,633,799 | - |
| 59 | RLAY | Relay Therapeutics, Inc. | 4.25B | 2.27% | 2,936,414 | 10.35M |
| 60 | TNGX | Tango Therapeutics, Inc. | 3.89B | -0.69% | 1,943,939 | 53.81M |
| 61 | IDYA | IDEAYA Biosciences, Inc. | 3.67B | 1.87% | 658,012 | 234.13M |
| 62 | TLX | Telix Pharmaceuticals Limited | 3.65B | 3.13% | 235,287 | 890.79M |
| 63 | PBLS | Parabilis Medicines, Inc. | 3.65B | -2.48% | 572,541 | 148.00K |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.64B | -1.18% | 1,698,995 | 7.50M |
| 65 | LEGN | Legend Biotech Corporation | 3.64B | 1.10% | 1,763,284 | 1.27B |
| 66 | CELC | Celcuity Inc. | 3.60B | 2.11% | 1,718,387 | - |
| 67 | ACAD | Acadia Pharmaceuticals Inc. | 3.47B | 0.80% | 3,152,355 | 1.14B |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.42B | -2.20% | 6,277,356 | - |
| 69 | ELVN | Enliven Therapeutics, Inc. | 3.33B | -3.19% | 821,505 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.27B | 1.99% | 939,607 | 606.33M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.18B | -0.45% | 1,717,655 | 3.60M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 3.16B | -0.04% | 2,310,343 | 463.98M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.15B | 1.23% | 1,390,862 | 117.00M |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.88B | 1.58% | 4,377,364 | - |
| 75 | ZLAB | Zai Lab Limited | 2.88B | 5.30% | 787,360 | 449.61M |
| 76 | MBX | MBX Biosciences, Inc. | 2.82B | 0.05% | 583,214 | - |
| 77 | PGEN | Precigen, Inc. | 2.77B | -9.37% | 10,254,123 | 85.72M |
| 78 | NAMS | NewAmsterdam Pharma Company N.V. | 2.73B | -1.72% | 1,182,352 | 7.12M |
| 79 | BEAM | Beam Therapeutics Inc. | 2.57B | 4.78% | 2,001,780 | 156.04M |
| 80 | RXRX | Recursion Pharmaceuticals, Inc. | 2.56B | 16.02% | 67,278,675 | 54.86M |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.56B | 2.97% | 1,257,865 | 158.00K |
| 82 | IRON | Disc Medicine, Inc. | 2.43B | -1.83% | 456,322 | - |
| 83 | IMNM | Immunome, Inc. | 2.40B | 1.29% | 1,216,227 | 4.02M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.37B | -0.48% | 1,006,532 | 36.77M |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.35B | -0.94% | 4,514,190 | - |
| 86 | HRMY | Harmony Biosciences Holdings, Inc. | 2.32B | 0.71% | 897,920 | 959.90M |
| 87 | ADMA | ADMA Biologics, Inc. | 2.26B | 4.01% | 3,512,369 | 512.28M |
| 88 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.21B | 7.85% | 2,630,381 | 208.78M |
| 89 | VRDN | Viridian Therapeutics, Inc. | 2.15B | -2.06% | 2,651,202 | 71.13M |
| 90 | VERA | Vera Therapeutics, Inc. | 2.15B | -1.94% | 2,715,140 | - |
| 91 | PHVS | Pharvaris N.V. | 2.14B | -2.24% | 816,234 | - |
| 92 | ADRX | ADARx Pharmaceuticals, Inc. | 2.13B | 4.38% | 913,953 | 6.13M |
| 93 | VCEL | Vericel Corporation | 2.10B | 2.29% | 648,584 | 306.30M |
| 94 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -0.69% | 802,893 | 311.51M |
| 95 | URGN | UroGen Pharma Ltd. | 2.09B | 3.33% | 1,276,526 | 188.73M |
| 96 | NVAX | Novavax, Inc. | 2.07B | 20.08% | 28,701,894 | 413.80M |
| 97 | MLYS | Mineralys Therapeutics, Inc. | 2.06B | -1.40% | 1,079,139 | - |
| 98 | FTRE | Fortrea Holdings Inc. | 2.01B | 5.55% | 2,266,623 | 2.68B |
| 99 | VIR | Vir Biotechnology, Inc. | 1.99B | 5.46% | 3,147,232 | 303.23M |
| 100 | ABSI | Absci Corporation | 1.98B | 4.16% | 4,294,896 | 1.56M |
| 101 | GPCR | Structure Therapeutics Inc. | 1.97B | -0.29% | 1,868,289 | - |
| 102 | BHVN | Biohaven Ltd. | 1.96B | 0.78% | 1,671,734 | - |
| 103 | TRVI | Trevi Therapeutics, Inc. | 1.95B | -1.37% | 1,719,316 | - |
| 104 | LKFT | Lakefront Biotherapeutics NV | 1.92B | 0.48% | 439,658 | 1.13B |
| 105 | XNCR | Xencor, Inc. | 1.91B | 3.18% | 1,276,618 | 104.97M |
| 106 | PVLA | Palvella Therapeutics, Inc. | 1.90B | -0.23% | 142,876 | - |
| 107 | AGIO | Agios Pharmaceuticals, Inc. | 1.87B | -1.73% | 808,718 | 98.34M |
| 108 | ZYME | Zymeworks Inc. | 1.86B | 4.21% | 1,036,952 | 37.13M |
| 109 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -0.06% | 2,198,641 | 1.97B |
| 110 | ZBIO | Zenas BioPharma, Inc. | 1.81B | -1.66% | 1,131,916 | 1.00M |
| 111 | NTLA | Intellia Therapeutics, Inc. | 1.79B | 4.00% | 4,967,541 | 59.51M |
| 112 | GENB | Generate Biomedicines, Inc. | 1.79B | 1.61% | 1,120,020 | 26.48M |
| 113 | MESO | Mesoblast Limited | 1.78B | 0.99% | 181,077 | 120.25M |
| 114 | SEPN | Septerna, Inc. | 1.77B | 0.42% | 266,681 | 98.88M |
| 115 | BRVE | Braveheart Bio, Inc. | 1.76B | 0.38% | 888,960 | - |
| 116 | NUVB | Nuvation Bio Inc. | 1.74B | -3.70% | 9,965,604 | 169.90M |
| 117 | STOK | Stoke Therapeutics, Inc. | 1.63B | -1.17% | 928,392 | 27.59M |
| 118 | OCUL | Ocular Therapeutix, Inc. | 1.59B | 4.17% | 5,620,002 | 52.06M |
| 119 | SNDX | Syndax Pharmaceuticals, Inc. | 1.59B | 1.31% | 1,459,828 | 252.25M |
| 120 | QURE | uniQure N.V. | 1.58B | -2.81% | 3,041,928 | 18.67M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.54B | 0.06% | 198,868 | 20.00M |
| 122 | IMCR | Immunocore Holdings plc | 1.52B | -0.40% | 329,451 | 430.78M |
| 123 | GHRS | GH Research PLC | 1.52B | -3.36% | 206,965 | - |
| 124 | INVA | Innoviva, Inc. | 1.49B | 0.68% | 993,390 | 440.00M |
| 125 | ANAB | AnaptysBio, Inc. | 1.47B | 1.38% | 595,547 | 106.09M |
| 126 | MAZE | Maze Therapeutics, Inc. | 1.47B | - | 588,015 | 20.00M |
| 127 | TSHA | Taysha Gene Therapies, Inc. | 1.46B | -3.02% | 4,975,354 | 5.49M |
| 128 | NKTR | Nektar Therapeutics | 1.44B | -3.12% | 2,029,306 | 54.59M |
| 129 | TYRA | Tyra Biosciences, Inc. | 1.44B | 2.45% | 614,361 | - |
| 130 | COAG | Hemab Therapeutics Holdings, Inc. | 1.43B | -1.67% | 294,545 | - |
| 131 | RARE | Ultragenyx Pharmaceutical Inc. | 1.43B | -4.73% | 4,656,685 | 717.00M |
| 132 | KARD | Kardigan, Inc. | 1.42B | 3.04% | 380,859 | - |
| 133 | KLRA | Kailera Therapeutics, Inc. | 1.41B | 4.33% | 1,811,909 | - |
| 134 | AVBP | ArriVent BioPharma, Inc. | 1.40B | 0.67% | 494,758 | - |
| 135 | KRSA | Korsana Biosciences, Inc. | 1.40B | 0.75% | 104,270 | - |
| 136 | INBX | Inhibrx Biosciences, Inc. | 1.39B | -2.51% | 207,091 | 1.30M |
| 137 | DRTS | Alpha Tau Medical Ltd. | 1.37B | 0.81% | 342,443 | - |
| 138 | OMER | Omeros Corporation | 1.37B | 1.56% | 1,068,177 | 38.42M |
| 139 | AAPG | Ascentage Pharma Group International | 1.31B | -4.98% | 3,588 | 94.61M |
| 140 | ORIC | ORIC Pharmaceuticals, Inc. | 1.29B | 2.29% | 1,395,685 | - |
| 141 | NBTX | Nanobiotix S.A. | 1.27B | -2.52% | 194,238 | 13.15M |
| 142 | DMRA | Damora Therapeutics, Inc. | 1.25B | -2.08% | 556,057 | - |
| 143 | REPL | Replimune Group, Inc. | 1.24B | 0.61% | 2,275,898 | - |
| 144 | MNKD | MannKind Corporation | 1.23B | 0.53% | 2,876,345 | 393.63M |
| 145 | SVRA | Savara Inc. | 1.21B | -0.62% | 2,862,732 | - |
| 146 | AVLN | Avalyn Pharma Inc. | 1.20B | -3.91% | 427,272 | - |
| 147 | TRAX | First Tracks Biotherapeutics, Inc. | 1.18B | -0.87% | 667,813 | - |
| 148 | BCAX | Bicara Therapeutics Inc. | 1.14B | -1.93% | 640,749 | - |
| 149 | LBRX | LB Pharmaceuticals Inc | 1.12B | -6.41% | 494,495 | - |
| 150 | LTGO | Latigo Biotherapeutics, Inc. | 1.10B | 4.59% | 589,999 | - |
| 151 | VOR | Vor Biopharma Inc. | 1.10B | -0.59% | 648,600 | - |
| 152 | IMTX | Immatics N.V. | 1.06B | 1.84% | 554,120 | 47.65M |
| 153 | MGTX | MeiraGTx Holdings plc | 1.05B | 1.20% | 941,654 | 397.50M |
| 154 | CGEM | Cullinan Therapeutics, Inc. | 1.03B | 3.42% | 1,082,966 | - |
| 155 | AKTS | Aktis Oncology, Inc. | 1.03B | - | 282,981 | 10.06M |
| 156 | JANX | Janux Therapeutics, Inc. | 1.01B | -2.30% | 533,741 | 24.00M |
| 157 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.01B | 21.30% | 7,690,855 | 132.42M |
| 158 | ODTX | Odyssey Therapeutics, Inc. | 998.62M | 0.53% | 171,782 | 99.00K |
| 159 | SPTX | Seaport Therapeutics, Inc. | 990.32M | 0.43% | 172,571 | - |
| 160 | ANL | Adlai Nortye Group Ltd. | 968.54M | -0.33% | 460,576 | 18.06M |
| 161 | MLTX | MoonLake Immunotherapeutics | 968.51M | -0.26% | 1,867,254 | - |
| 162 | KURA | Kura Oncology, Inc. | 944.76M | -0.28% | 1,294,991 | 77.23M |
| 163 | ANRO | Alto Neuroscience, Inc. | 942.20M | -3.19% | 550,294 | - |
| 164 | ABUS | Arbutus Biopharma Corporation | 923.95M | 4.94% | 6,183,039 | 181.72M |
| 165 | SLBT | SL Science Holding Limited | 906.72M | 1.27% | 80,867 | 3.27M |
| 166 | APMD | Apnimed, Inc. | 905.47M | 1.12% | 340,303 | 115.12M |
| 167 | CRVS | Corvus Pharmaceuticals, Inc. | 903.46M | -1.47% | 825,385 | - |
| 168 | JBIO | Jade Biosciences, Inc. | 894.82M | -0.35% | 607,057 | - |
| 169 | RIGL | Rigel Pharmaceuticals, Inc. | 892.71M | 1.36% | 391,628 | 276.79M |
| 170 | ALMS | Alumis Inc. | 885.34M | -0.15% | 3,871,900 | 7.40M |
| 171 | GLUE | Monte Rosa Therapeutics, Inc. | 876.17M | -2.19% | 1,749,263 | 28.73M |
| 172 | SANA | Sana Biotechnology, Inc. | 862.16M | -0.35% | 5,394,074 | - |
| 173 | SGP | SpyGlass Pharma, Inc. | 855.93M | 2.69% | 133,105 | - |
| 174 | OBX | Obsidian Therapeutics, Inc. | 854.94M | 1.84% | 199,186 | - |
| 175 | ARDX | Ardelyx, Inc. | 844.75M | 1.50% | 4,253,036 | 450.89M |
| 176 | IMMX | Immix Biopharma, Inc. | 839.81M | 4.65% | 1,597,501 | - |
| 177 | HELP | Helus Pharma Inc. | 834.35M | -2.39% | 1,325,305 | - |
| 178 | ATTO | Attovia Therapeutics, Inc. | 821.49M | 4.80% | 455,959 | 1.80M |
| 179 | IVA | Inventiva S.A. | 797.22M | -2.25% | 1,701,580 | 2.81M |
| 180 | ANNX | Annexon, Inc. | 796.23M | 0.24% | 3,448,838 | - |
| 181 | AVTX | Avalo Therapeutics, Inc. | 783.00M | -2.60% | 736,839 | 59.00K |
| 182 | CADL | Candel Therapeutics, Inc. | 782.78M | 0.49% | 980,886 | - |
| 183 | GYRE | Gyre Therapeutics, Inc. | 779.35M | 3.38% | 181,458 | 109.82M |
| 184 | GERN | Geron Corporation | 777.39M | 0.83% | 6,366,748 | 204.56M |
| 185 | DSGN | Design Therapeutics, Inc. | 777.26M | 0.65% | 680,775 | - |
| 186 | LXRX | Lexicon Pharmaceuticals, Inc. | 774.22M | -4.40% | 2,716,386 | 41.47M |
| 187 | SLDB | Solid Biosciences Inc. | 757.01M | 3.07% | 1,372,173 | - |
| 188 | WVE | Wave Life Sciences, Inc. | 738.93M | -0.79% | 3,514,892 | 65.37M |
| 189 | VSTM | Verastem, Inc. | 724.51M | 3.90% | 2,217,136 | 87.53M |
| 190 | OLMA | Olema Pharmaceuticals, Inc. | 721.86M | 0.24% | 1,006,119 | - |
| 191 | ACHV | Achieve Life Sciences, Inc. | 721.35M | -3.18% | 1,704,574 | - |
| 192 | OABI | OmniAb, Inc. | 715.32M | 1.03% | 1,216,108 | 38.46M |
| 193 | FDMT | 4D Molecular Therapeutics, Inc. | 713.76M | -5.49% | 2,110,579 | 92.01M |
| 194 | FTH | Faeth Therapeutics, Inc. | 700.28M | -4.41% | 412,835 | - |
| 195 | NVCT | Nuvectis Pharma, Inc. | 696.92M | -2.42% | 194,271 | - |
| 196 | PHAR | Pharming Group N.V. | 693.58M | 0.51% | 10,814 | 366.48M |
| 197 | MDXG | MiMedx Group, Inc. | 663.21M | -0.87% | 894,726 | 355.17M |
| 198 | STTK | Shattuck Labs, Inc. | 652.36M | -3.42% | 1,239,353 | 1.00M |
| 199 | AURA | Aura Biosciences, Inc. | 645.04M | 2.13% | 589,814 | - |
| 200 | SGMT | Sagimet Biosciences Inc. | 640.31M | -1.20% | 1,528,740 | - |
| 201 | ZVRA | Zevra Therapeutics, Inc. | 635.41M | 7.11% | 1,977,765 | 136.07M |
| 202 | CLYM | Climb Bio, Inc. | 634.67M | 1.01% | 1,206,413 | - |
| 203 | BLSM | BlossomHill Therapeutics, Inc. | 633.79M | 1.27% | 201,550 | - |
| 204 | ACRS | Aclaris Therapeutics, Inc. | 628.54M | -2.73% | 7,015,491 | 8.22M |
| 205 | DBVT | DBV Technologies S.A. | 615.65M | -1.04% | 224,452 | 5.04M |
| 206 | ETRA | Electra Therapeutics, Inc. | 611.35M | -6.08% | 334,447 | - |
| 207 | SLN | Silence Therapeutics plc | 610.52M | -4.70% | 976,297 | 615.00K |
| 208 | CBIO | Crescent Biopharma, Inc. | 596.65M | -2.65% | 187,006 | 11.88M |
| 209 | PRME | Prime Medicine, Inc. | 571.07M | 7.72% | 4,716,863 | 4.07M |
| 210 | CRMD | CorMedix Inc. | 565.88M | 0.97% | 1,257,332 | 462.25M |
| 211 | CTMX | CytomX Therapeutics, Inc. | 562.18M | 0.78% | 1,767,319 | 18.30M |
| 212 | VALN | Valneva SE | 542.73M | 1.31% | 69,379 | 163.30M |
| 213 | PHAT | Phathom Pharmaceuticals, Inc. | 532.18M | -3.18% | 1,104,735 | 239.66M |
| 214 | NGNE | Neurogene Inc. | 529.70M | 3.20% | 211,774 | 925.00K |
| 215 | OCS | Oculis Holding AG | 528.43M | -1.95% | 242,001 | 1.45M |
| 216 | MNPR | Monopar Therapeutics Inc. | 525.50M | 0.41% | 128,262 | - |
| 217 | ALT | Altimmune, Inc. | 519.36M | -2.38% | 3,839,540 | 31.00K |
| 218 | ALLO | Allogene Therapeutics, Inc. | 518.24M | - | 4,443,266 | 4.64M |
| 219 | MPLT | MapLight Therapeutics, Inc. | 515.46M | -5.55% | 262,133 | - |
| 220 | RGNX | REGENXBIO Inc. | 512.26M | 4.44% | 2,353,594 | 174.48M |
| 221 | EPRX | Eupraxia Pharmaceuticals Inc. | 508.52M | 6.98% | 1,774,895 | - |
| 222 | YDES | YD Bio Limited | 503.61M | -12.33% | 258,509 | 1.24M |
| 223 | DRUG | Bright Minds Biosciences Inc. | 502.29M | -1.78% | 55,951 | - |
| 224 | PBYI | Puma Biotechnology, Inc. | 499.17M | 1.68% | 297,628 | 231.24M |
| 225 | ARVN | Arvinas, Inc. | 487.78M | 0.67% | 628,531 | 316.70M |
| 226 | AUTL | Autolus Therapeutics plc | 487.08M | 2.81% | 2,521,524 | 117.39M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 478.54M | -3.05% | 508,398 | - |
| 228 | PROK | ProKidney Corp. | 477.67M | -8.14% | 985,936 | 818.00K |
| 229 | ASMB | Assembly Biosciences, Inc. | 463.00M | 0.89% | 241,748 | 74.85M |
| 230 | OVID | Ovid Therapeutics Inc. | 457.00M | -1.68% | 1,200,104 | 1.58M |
| 231 | RZLT | Rezolute, Inc. | 454.20M | 7.98% | 4,197,536 | - |
| 232 | DMAC | DiaMedica Therapeutics Inc. | 454.05M | 2.31% | 231,379 | - |
| 233 | ENTX | Entera Bio Ltd. | 453.63M | -8.39% | 1,254,986 | 42.00K |
| 234 | CAPR | Capricor Therapeutics, Inc. | 452.32M | -13.07% | 6,771,863 | 11.13M |
| 235 | TECX | Tectonic Therapeutic, Inc. | 451.79M | 2.53% | 312,646 | - |
| 236 | EDIT | Editas Medicine, Inc. | 428.49M | 6.49% | 3,019,176 | 47.01M |
| 237 | AGMB | AgomAb Therapeutics NV | 427.96M | 1.52% | 129,804 | - |
| 238 | SPRY | ARS Pharmaceuticals, Inc. | 426.63M | 5.41% | 1,621,611 | 116.93M |
| 239 | PRTA | Prothena Corporation plc | 424.56M | -1.08% | 714,463 | 54.53M |
| 240 | ARCT | Arcturus Therapeutics Holdings Inc. | 416.68M | 12.51% | 1,316,537 | 29.37M |
| 241 | AVIR | Atea Pharmaceuticals, Inc. | 411.45M | - | 293,607 | - |
| 242 | EIKN | Eikon Therapeutics, Inc. | 408.40M | 2.86% | 485,357 | - |
| 243 | AGEN | Agenus Inc. | 393.03M | 4.43% | 956,304 | 132.69M |
| 244 | KYTX | Kyverna Therapeutics, Inc. | 390.85M | 1.61% | 813,485 | - |
| 245 | PRLD | Prelude Therapeutics Incorporated | 388.29M | 2.72% | 325,276 | 22.42M |
| 246 | VTVT | vTv Therapeutics Inc. | 376.84M | -0.79% | 14,858 | 36.84M |
| 247 | ZURA | Zura Bio Limited | 376.61M | -4.38% | 2,651,673 | - |
| 248 | GALT | Galectin Therapeutics Inc. | 376.17M | -4.36% | 280,835 | - |
| 249 | FENC | Fennec Pharmaceuticals Inc. | 372.41M | 4.12% | 118,018 | 59.22M |
| 250 | RLMD | Relmada Therapeutics, Inc. | 371.21M | -3.33% | 1,282,547 | - |
| 251 | TTRX | Turn Therapeutics Inc. | 368.18M | -7.28% | 111,344 | - |
| 252 | CCCC | C4 Therapeutics, Inc. | 367.85M | 1.36% | 1,463,584 | 35.04M |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 366.98M | -2.78% | 218,875 | 65.26M |
| 254 | IRD | Opus Genetics, Inc. | 364.40M | -4.37% | 2,537,833 | 9.86M |
| 255 | IKT | Inhibikase Therapeutics, Inc. | 364.15M | - | 407,492 | 1.00 |
| 256 | OBIO | Orchestra BioMed Holdings, Inc. | 362.43M | 1.34% | 284,801 | 31.98M |
| 257 | OCGN | Ocugen, Inc. | 352.67M | 1.96% | 5,495,756 | 4.58M |
| 258 | CABA | Cabaletta Bio, Inc. | 352.65M | 4.00% | 5,407,207 | - |
| 259 | ARTV | Artiva Biotherapeutics, Inc. | 348.59M | 4.39% | 473,193 | 251.00K |
| 260 | SRZN | Surrozen, Inc. | 342.38M | -0.65% | 439,184 | 11.51M |
| 261 | INDP | Indaptus Therapeutics, Inc. | 334.44M | 5.46% | 361,477 | - |
| 262 | BNTC | Benitec Biopharma Inc. | 321.97M | 2.78% | 584,241 | - |
| 263 | SCTX | Scribe Therapeutics Inc. | 306.88M | -3.45% | 1,107,731 | 33.30M |
| 264 | LRMR | Larimar Therapeutics, Inc. | 298.54M | -3.38% | 886,144 | - |
| 265 | ABEO | Abeona Therapeutics Inc. | 292.21M | 1.59% | 1,403,678 | 25.52M |
| 266 | FATE | Fate Therapeutics, Inc. | 291.16M | 4.74% | 3,381,444 | 6.49M |
| 267 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 288.63M | -7.46% | 481,655 | - |
| 268 | XFOR | X4 Pharmaceuticals, Inc. | 287.53M | 2.47% | 698,104 | 15.85M |
| 269 | RCKT | Rocket Pharmaceuticals, Inc. | 286.51M | 1.95% | 1,659,065 | - |
| 270 | CUVL | Clinuvel Pharmaceuticals Limited | 285.72M | -4.81% | 9,623 | 65.05M |
| 271 | FULC | Fulcrum Therapeutics, Inc. | 283.06M | 0.54% | 1,062,212 | 80.00M |
| 272 | SABS | SAB Biotherapeutics, Inc. | 282.06M | 4.03% | 866,272 | 114.70K |
| 273 | BCYC | Bicycle Therapeutics plc | 280.67M | 18.64% | 1,846,468 | 61.21M |
| 274 | LXEO | Lexeo Therapeutics, Inc. | 279.76M | -3.40% | 1,858,571 | - |
| 275 | VNDA | Vanda Pharmaceuticals Inc. | 276.92M | -1.08% | 726,796 | 215.72M |
| 276 | EYPT | EyePoint, Inc. | 271.57M | -3.08% | 2,763,907 | 2.79M |
| 277 | ACIU | AC Immune SA | 269.45M | -0.55% | 221,399 | 21.67M |
| 278 | IPSC | Century Therapeutics, Inc. | 267.99M | -3.27% | 773,851 | 109.16M |
| 279 | PYXS | Pyxis Oncology, Inc. | 267.58M | 4.67% | 1,516,929 | 11.04M |
| 280 | UPB | Upstream Bio, Inc. | 265.64M | -3.77% | 1,010,579 | 3.16M |
| 281 | ZNTL | Zentalis Pharmaceuticals, Inc. | 263.19M | 10.32% | 2,994,948 | 26.87M |
| 282 | IMRX | Immuneering Corporation | 261.38M | -0.74% | 482,714 | - |
| 283 | SLGL | Sol-Gel Technologies Ltd. | 258.48M | 9.65% | 29,250 | 1.80M |
| 284 | VOGX | Vogenx, Inc. | 254.76M | -5.92% | 60,962 | - |
| 285 | PALI | Palisade Bio, Inc. | 254.44M | 1.39% | 1,600,940 | 500.00K |
| 286 | CAMP | Camp4 Therapeutics Corporation | 251.64M | 0.25% | 381,158 | 4.22M |
| 287 | STRO | Sutro Biopharma, Inc. | 250.87M | -1.43% | 160,398 | 45.70M |
| 288 | VCRE | Vicore Pharma Holding AB (publ) | 249.21M | -3.54% | 11,874 | 412.09K |
| 289 | QTTB | Q32 Bio Inc. | 249.17M | 1.70% | 955,754 | 53.74M |
| 290 | GLSI | Greenwich LifeSciences, Inc. | 248.21M | -0.41% | 98,729 | - |
| 291 | IFRX | InflaRx N.V. | 247.58M | -2.33% | 701,008 | -11.54K |
| 292 | IVVD | Invivyd, Inc. | 247.36M | 2.08% | 5,425,521 | 58.37M |
| 293 | EVMN | Evommune, Inc. | 241.34M | -3.90% | 1,365,172 | 10.00M |
| 294 | MGNX | MacroGenics, Inc. | 240.15M | 5.31% | 605,945 | 175.14M |
| 295 | NAUT | Nautilus Biotechnology, Inc. | 237.97M | -4.59% | 29,556,121 | 190.00K |
| 296 | PRQR | ProQR Therapeutics N.V. | 235.67M | 2.14% | 720,690 | 21.05M |
| 297 | LCTX | Lineage Cell Therapeutics, Inc. | 234.55M | -0.31% | 1,386,588 | 13.08M |
| 298 | KROS | Keros Therapeutics, Inc. | 228.41M | 1.41% | 132,408 | 15.01M |
| 299 | LYEL | Lyell Immunopharma, Inc. | 222.26M | -2.05% | 129,452 | 27.00K |
| 300 | ALEC | Alector, Inc. | 222.20M | 9.94% | 89,983,690 | 13.86M |
| 301 | SION | Sionna Therapeutics, Inc. | 219.28M | -1.22% | 1,097,395 | - |
| 302 | CGEN | Compugen Ltd. | 218.81M | - | 198,865 | 74.00M |
| 303 | PLX | Protalix BioTherapeutics, Inc. | 218.35M | - | 984,061 | 80.62M |
| 304 | RNAC | Cartesian Therapeutics, Inc. | 216.02M | -2.99% | 226,262 | 1.48M |
| 305 | ANTX | AN2 Therapeutics, Inc. | 211.70M | -1.75% | 299,950 | - |
| 306 | WHWK | Whitehawk Therapeutics, Inc. | 210.93M | - | 289,138 | 7.15M |
| 307 | ELDN | Eledon Pharmaceuticals, Inc. | 203.35M | 0.40% | 725,896 | - |
| 308 | ACOG | Alpha Cognition Inc. | 199.27M | 0.55% | 52,593 | 15.26M |
| 309 | TRDA | Entrada Therapeutics, Inc. | 197.59M | 1.86% | 463,809 | 4.69M |
| 310 | NGEN | NervGen Pharma Corp. | 194.62M | 1.69% | 441,039 | - |
| 311 | ORMP | Oramed Pharmaceuticals Inc. | 189.27M | 1.34% | 104,134 | 2.00M |
| 312 | YARW | Yarrow Bioscience, Inc. | 188.88M | -8.85% | 102,512 | - |
| 313 | ADAG | Adagene Inc. | 188.00M | -1.75% | 325,707 | 9.29M |
| 314 | CNTN | Canton Strategic Holdings, Inc. | 185.66M | 3.56% | 739,344 | 1.50M |
| 315 | NKTX | Nkarta, Inc. | 181.21M | -1.75% | 522,107 | - |
| 316 | CUE | Cue Biopharma, Inc. | 176.96M | -4.73% | 272,651 | 37.66M |
| 317 | MDWD | MediWound Ltd. | 174.42M | -0.07% | 49,887 | 11.86M |
| 318 | DTIL | Precision BioSciences, Inc. | 174.17M | - | 219,029 | 45.06M |
| 319 | CHRS | Coherus Oncology, Inc. | 173.04M | -3.45% | 2,009,495 | 50.94M |
| 320 | CMPX | Compass Therapeutics, Inc. | 172.99M | 12.13% | 15,831,951 | 850.00K |
| 321 | MSLE | Satellos Bioscience Inc. | 171.30M | -5.29% | 24,845 | - |
| 322 | ALXO | ALX Oncology Holdings Inc. | 167.32M | -0.82% | 1,788,732 | - |
| 323 | PEPG | PepGen Inc. | 163.45M | 3.51% | 607,425 | - |
| 324 | VRXA | Veraxa Biotech AG | 159.79M | - | 154,077 | 29.54K |
| 325 | NERV | Minerva Neurosciences, Inc. | 158.52M | 1.22% | 72,356 | - |
| 326 | NBP | NovaBridge Biosciences | 157.76M | 0.37% | 184,989 | - |
| 327 | TARA | Protara Therapeutics, Inc. | 155.42M | -2.59% | 1,397,597 | - |
| 328 | ABOS | Acumen Pharmaceuticals, Inc. | 154.04M | 4.41% | 713,981 | - |
| 329 | AVXL | Anavex Life Sciences Corp. | 152.49M | -9.62% | 2,031,597 | - |
| 330 | CDXS | Codexis, Inc. | 152.21M | 2.21% | 894,327 | 77.68M |
| 331 | MENS | Jyong Biotech Ltd. | 152.18M | -5.96% | 47,373 | - |
| 332 | VYGR | Voyager Therapeutics, Inc. | 151.58M | 0.41% | 1,391,961 | 34.46M |
| 333 | MOLN | Molecular Partners AG | 149.79M | 0.26% | 757 | 856.30K |
| 334 | KRRO | Korro Bio, Inc. | 146.81M | 3.42% | 112,218 | 2.38M |
| 335 | OTLK | Outlook Therapeutics, Inc. | 144.97M | 0.42% | 4,687,734 | -1.16M |
| 336 | HUMA | Humacyte, Inc. | 138.90M | -4.12% | 6,449,386 | 2.12M |
| 337 | IPHA | Innate Pharma S.A. | 138.64M | 1.28% | 107,788 | 11.21M |
| 338 | TNXP | Tonix Pharmaceuticals Holding Corp. | 138.41M | -9.43% | 1,142,964 | 29.10M |
| 339 | TLSA | Tiziana Life Sciences Ltd | 138.36M | -4.46% | 274,642 | - |
| 340 | RNA | Atrium Therapeutics, Inc. | 136.33M | 1.66% | 268,285 | 35.84M |
| 341 | ARMP | Armata Pharmaceuticals, Inc. | 136.09M | 3.98% | 56,679 | 5.54M |
| 342 | PMVP | PMV Pharmaceuticals, Inc. | 134.41M | -0.56% | 1,185,465 | - |
| 343 | SPRB | Spruce Biosciences, Inc. | 130.54M | -0.63% | 65,087 | 697.00K |
| 344 | SEER | Seer, Inc. | 129.02M | 3.56% | 595,875 | 14.22M |
| 345 | CBUS | Cibus, Inc. | 128.40M | -1.75% | 231,397 | 4.35M |
| 346 | KZIA | Kazia Therapeutics Limited | 128.13M | 0.86% | 240,613 | 1.27M |
| 347 | CRBU | Caribou Biosciences, Inc. | 127.58M | -2.46% | 1,546,867 | 10.04M |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 126.49M | - | 2,869,376 | 1.34M |
| 349 | ENGN | enGene Therapeutics Inc. | 125.32M | -3.61% | 952,872 | - |
| 350 | NRXP | NRx Pharmaceuticals, Inc. | 124.16M | -1.20% | 680,823 | 3.39M |
| 351 | HURA | TuHURA Biosciences, Inc. | 119.17M | -2.09% | 335,529 | - |
| 352 | INO | Inovio Pharmaceuticals, Inc. | 118.91M | -0.86% | 2,960,275 | 65.34K |
| 353 | FHTX | Foghorn Therapeutics Inc. | 118.77M | -0.99% | 987,959 | 36.74M |
| 354 | UNCY | Unicycive Therapeutics, Inc. | 116.71M | -0.71% | 681,401 | - |
| 355 | GNLX | Genelux Corporation | 116.51M | 1.56% | 317,345 | 8.00K |
| 356 | AARD | Aardvark Therapeutics, Inc. | 114.24M | 4.61% | 62,253 | - |
| 357 | COYA | Coya Therapeutics, Inc. | 113.77M | 0.83% | 117,247 | 8.02M |
| 358 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 113.15M | -4.57% | 793,491 | - |
| 359 | LENZ | LENZ Therapeutics, Inc. | 112.80M | 0.28% | 777,424 | 21.48M |
| 360 | TENX | Tenax Therapeutics, Inc. | 112.27M | -1.01% | 1,468,364 | - |
| 361 | BDTX | Black Diamond Therapeutics, Inc. | 111.46M | 2.65% | 839,141 | 70.00M |
| 362 | IMUX | Immunic, Inc. | 110.11M | 1.38% | 491,257 | - |
| 363 | VANI | Vivani Medical, Inc. | 110.05M | -0.81% | 95,579 | - |
| 364 | MIST | Milestone Pharmaceuticals Inc. | 109.83M | -3.74% | 1,084,583 | 2.34M |
| 365 | RANI | Rani Therapeutics Holdings, Inc. | 108.02M | -4.43% | 582,531 | 4.88M |
| 366 | OKUR | OnKure Therapeutics, Inc. | 106.51M | 2.73% | 632,342 | - |
| 367 | PYPD | PolyPid Ltd. | 105.62M | 0.19% | 102,016 | - |
| 368 | TVGN | Tevogen Inc. | 103.86M | -5.44% | 3,477 | - |
| 369 | PLYX | Polaryx Therapeutics, Inc. | 103.18M | -0.48% | 40,068 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 102.55M | - | 369,464 | - |
| 371 | CLLS | Cellectis S.A. | 101.78M | -1.40% | 37,268 | 63.82M |
| 372 | NMRA | Neumora Therapeutics, Inc. | 98.70M | 5.08% | 2,989,618 | - |
| 373 | ATRA | Atara Biotherapeutics, Inc. | 94.35M | -0.84% | 39,319 | 6.19M |
| 374 | BMEA | Biomea Fusion, Inc. | 94.23M | 2.36% | 1,044,352 | - |
| 375 | EQ | Equillium, Inc. | 91.94M | 2.84% | 795,620 | 4.39M |
| 376 | NTRB | Nutriband Inc. | 90.80M | 2.61% | 19,475 | 1.62M |
| 377 | NRXS | NeurAxis, Inc. | 89.79M | 0.56% | 53,777 | 5.32M |
| 378 | RLYB | Rallybio Corporation | 89.75M | -1.05% | 4,632 | 646.00K |
| 379 | CGTX | Cognition Therapeutics, Inc. | 89.21M | 1.41% | 331,792 | - |
| 380 | CRDF | Cardiff Oncology, Inc. | 88.69M | 1.79% | 451,951 | 508.00K |
| 381 | ICCC | ImmuCell Corporation | 88.55M | - | 11,262 | 30.68M |
| 382 | CNXU | Conexeu Sciences Inc. | 88.00M | 0.65% | 171,270 | - |
| 383 | MNOV | MediciNova, Inc. | 86.38M | -1.40% | 216,978 | 920.48K |
| 384 | ACRV | Acrivon Therapeutics, Inc. | 84.85M | -0.50% | 402,171 | - |
| 385 | PMN | ProMIS Neurosciences, Inc. | 84.03M | -0.32% | 38,205 | - |
| 386 | TELO | Telomir Pharmaceuticals, Inc. | 83.22M | 2.54% | 134,371 | - |
| 387 | PTHS | Pelthos Therapeutics Inc. | 78.48M | -0.49% | 69,651 | 43.30M |
| 388 | OKYO | OKYO Pharma Limited | 77.14M | - | 11,232 | - |
| 389 | ONCY | Oncolytics Biotech Inc. | 76.11M | -5.40% | 1,939,589 | - |
| 390 | VRCA | Verrica Pharmaceuticals Inc. | 74.04M | -1.60% | 35,043 | 30.32M |
| 391 | OSTX | OS Therapies Incorporated | 73.80M | -1.23% | 416,202 | - |
| 392 | GANX | Gain Therapeutics, Inc. | 73.76M | -1.17% | 351,044 | - |
| 393 | NTHI | NeOnc Technologies Holdings, Inc. | 72.58M | -2.34% | 197,301 | 39.99K |
| 394 | IBIO | iBio, Inc. | 72.02M | -0.44% | 1,126,797 | 100.00K |
| 395 | MAIA | MAIA Biotechnology, Inc. | 71.77M | -0.84% | 531,014 | - |
| 396 | RNTX | Rein Therapeutics Inc. | 71.17M | 3.03% | 336,292 | - |
| 397 | HRTX | Heron Therapeutics, Inc. | 70.25M | 6.44% | 2,935,870 | 151.18M |
| 398 | HYFT | MindWalk Holdings Corp. | 70.20M | 11.19% | 570,240 | 11.57M |
| 399 | FBIO | Fortress Biotech, Inc. | 69.70M | 2.96% | 553,820 | 68.47M |
| 400 | ACET | Adicet Bio, Inc. | 69.65M | -0.46% | 152,772 | - |
| 401 | CSBR | Champions Oncology, Inc. | 69.18M | 0.61% | 11,135 | 60.66M |
| 402 | CING | Cingulate Inc. | 69.07M | -0.21% | 139,937 | - |
| 403 | SPRO | Spero Therapeutics, Inc. | 67.55M | -2.52% | 942,725 | 47.00M |
| 404 | KLRS | Kalaris Therapeutics, Inc. | 67.37M | 4.81% | 27,390 | - |
| 405 | PDSB | PDS Biotechnology Corporation | 67.17M | 60.32% | 78,550,937 | - |
| 406 | ALPS | Alps Group Inc | 66.56M | 1.27% | 69,430 | 3.74M |
| 407 | XBIT | XBiotech Inc. | 66.46M | -0.46% | 32,741 | - |
| 408 | RNXT | RenovoRx, Inc. | 66.34M | -6.96% | 618,033 | 1.98M |
| 409 | GOSS | Gossamer Bio, Inc. | 65.08M | -0.56% | 391,009 | 53.29M |
| 410 | ATHE | Alterity Therapeutics Limited | 63.87M | -6.67% | 54,635 | 2.50M |
| 411 | PLRX | Pliant Therapeutics, Inc. | 63.78M | -0.48% | 295,616 | - |
| 412 | INKT | MiNK Therapeutics, Inc. | 62.26M | -1.93% | 28,584 | - |
| 413 | ELOX | Eloxx Pharmaceuticals, Inc. | 62.20M | -0.64% | 26,161 | - |
| 414 | MREO | Mereo BioPharma Group plc | 61.96M | 2.16% | 2,470,261 | 500.00K |
| 415 | GUTS | Fractyl Health, Inc. | 60.49M | -6.54% | 291,222 | 3.00K |
| 416 | HYPD | Hyperion DeFi, Inc. | 60.45M | 4.29% | 362,737 | 1.40M |
| 417 | XLO | Xilio Therapeutics, Inc. | 59.95M | 1.11% | 7,158 | 64.09M |
| 418 | BOLD | Boundless Bio, Inc. | 59.14M | -0.76% | 55,060 | - |
| 419 | CNTB | Connect Biopharma Holdings Limited | 56.54M | -3.14% | 1,431,191 | 2.95M |
| 420 | ALDX | Aldeyra Therapeutics, Inc. | 55.72M | -21.05% | 7,027,896 | - |
| 421 | CLNN | Clene Inc. | 55.58M | -4.17% | 278,243 | 197.00K |
| 422 | CELU | Celularity Inc. | 55.49M | 6.87% | 282,128 | 18.97M |
| 423 | INMB | INmune Bio Inc. | 53.84M | 0.52% | 267,251 | 50.00K |
| 424 | IMA | ImageneBio, Inc. | 53.35M | 2.17% | 8,533 | 800.00K |
| 425 | APLM | Apollomics, Inc. | 52.84M | - | - | 8.84M |
| 426 | EDSA | Edesa Biotech, Inc. | 52.83M | 1.30% | 69,953 | - |
| 427 | LONA | LeonaBio, Inc. | 52.57M | 15.77% | 296,081 | - |
| 428 | SER | Serina Therapeutics, Inc. | 51.82M | 4.08% | 25,271 | 130.00K |
| 429 | DWTX | Dogwood Therapeutics, Inc. | 51.67M | 4.11% | 99,973 | - |
| 430 | EXOZ | eXoZymes, Inc. | 51.23M | -4.33% | 4,451 | -700.00 |
| 431 | BSEM | BioStem Technologies, Inc. | 51.20M | 0.92% | 120,978 | 34.59M |
| 432 | ANVS | Annovis Bio, Inc. | 51.13M | 1.69% | 657,640 | - |
| 433 | ELTX | Elicio Therapeutics, Inc. | 50.46M | - | 202,848 | - |
| 434 | CRVO | CervoMed Inc. | 50.04M | 9.60% | 648,750 | 331.30K |
| 435 | TIL | Instil Bio, Inc. | 47.13M | -3.74% | 12,945 | - |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 45.20M | 0.20% | 239,077 | 21.00M |
| 437 | VERU | Veru Inc. | 43.48M | 1.59% | 88,767 | 16.89M |
| 438 | GRCE | Grace Therapeutics, Inc. | 43.33M | -0.48% | 80,043 | - |
| 439 | LITS | Lite Strategy, Inc. | 42.57M | 1.45% | 435,147 | - |
| 440 | CVM | CEL-SCI Corporation | 42.57M | 4.76% | 796,310 | - |
| 441 | FLNA | Filana Therapeutics, Inc. | 42.02M | -6.56% | 1,034,912 | - |
| 442 | IBO | Impact BioMedical Inc. | 41.35M | -9.02% | 17,339 | 35.00K |
| 443 | MGX | Metagenomi Therapeutics, Inc. | 39.29M | 1.96% | 163,205 | 13.56M |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 37.73M | 2.56% | 115,026 | 35.09M |
| 445 | NNVC | NanoViricides, Inc. | 37.01M | 13.28% | 708,540 | - |
| 446 | BCTX | BriaCell Therapeutics Corp. | 36.22M | 3.47% | 59,548 | - |
| 447 | ALGS | Aligos Therapeutics, Inc. | 33.72M | -2.53% | 48,609 | 31.52M |
| 448 | BYSI | BeyondSpring Inc. | 32.32M | -0.17% | 94,292 | 1.88M |
| 449 | IMMP | Immutep Limited | 31.84M | -1.84% | 25,193 | 13.79M |
| 450 | CNTX | Context Therapeutics Inc. | 30.92M | 8.65% | 1,001,327 | - |
| 451 | RNAZ | TransCode Therapeutics, Inc. | 29.80M | 12.10% | 65,725 | - |
| 452 | IGC | IGC Pharma, Inc. | 29.15M | 2.58% | 1,769,555 | 1.11M |
| 453 | MCRB | Seres Therapeutics, Inc. | 28.63M | -3.06% | 63,303 | 1.88M |
| 454 | QNCX | Quince Therapeutics, Inc. | 28.58M | -3.77% | 22,095 | - |
| 455 | ATYR | aTyr Pharma, Inc. | 28.45M | 0.97% | 1,810,080 | 190.00K |
| 456 | GRDX | GridAI Technologies Corp. | 27.12M | 0.52% | 191,962 | - |
| 457 | QNTM | Quantum BioPharma Ltd. | 26.45M | -4.94% | 246,765 | - |
| 458 | EVAX | Evaxion A/S | 26.27M | -1.56% | 38,243 | 7.49M |
| 459 | ABVC | ABVC BioPharma, Inc. | 25.41M | -2.97% | 93,532 | 797.92K |
| 460 | KYNB | Kyntra Bio, Inc. | 24.66M | -3.49% | 88,804 | 4.62M |
| 461 | ATOS | Atossa Therapeutics, Inc. | 24.45M | 4.70% | 53,315 | - |
| 462 | NXTC | NextCure, Inc. | 23.12M | -0.79% | 14,554 | - |
| 463 | PLRZ | Polyrizon Ltd. | 22.49M | -3.64% | 16,966 | - |
| 464 | QNRX | Quoin Pharmaceuticals, Ltd. | 21.88M | 1.90% | 26,509 | - |
| 465 | COCP | Cocrystal Pharma, Inc. | 21.38M | -3.06% | 41,304 | 330.00K |
| 466 | ACTU | Actuate Therapeutics, Inc. | 21.01M | 6.83% | 202,227 | - |
| 467 | AKTX | Akari Therapeutics, Plc | 20.43M | 2.52% | 9,562 | - |
| 468 | TCRX | TScan Therapeutics, Inc. | 20.02M | -7.86% | 758,195 | 7.11M |
| 469 | JSPR | Jasper Therapeutics, Inc. | 19.73M | 4.88% | 376,090 | - |
| 470 | PBM | Psyence Biomedical Ltd. | 19.38M | -1.55% | 145,551 | - |
| 471 | ESLA | Estrella Immunopharma, Inc. | 19.14M | -5.98% | 31,195 | - |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 18.67M | -0.58% | 15,461 | 1.17M |
| 473 | MRKR | Marker Therapeutics, Inc. | 17.67M | 0.95% | 73,490 | 3.55M |
| 474 | PTN | Palatin Technologies, Inc. | 17.45M | 1.61% | 13,007 | 13.19M |
| 475 | LPCN | Lipocine Inc. | 17.07M | 0.98% | 19,764 | 1.57M |
| 476 | DYAI | Dyadic International, Inc. | 16.54M | -0.39% | 142,861 | 3.80M |
| 477 | NCEL | NewcelX Ltd. | 16.52M | 0.35% | 4,087 | - |
| 478 | BCDA | BioCardia, Inc. | 16.50M | 4.81% | 148,934 | 3.00K |
| 479 | KPRX | Kiora Pharmaceuticals, Inc. | 16.10M | -1.17% | 8,569 | 20.00K |
| 480 | ALLR | Allarity Therapeutics, Inc. | 15.91M | -3.85% | 39,172 | 345.00K |
| 481 | CLRB | Cellectar Biosciences, Inc. | 15.79M | -6.18% | 60,682 | - |
| 482 | ICU | SeaStar Medical Holding Corporation | 15.64M | -24.31% | 599,740 | 1.71M |
| 483 | KPTI | Karyopharm Therapeutics Inc. | 15.21M | -16.42% | 1,983,904 | 146.62M |
| 484 | TVRD | Tvardi Therapeutics, Inc. | 15.21M | -0.87% | 148,917 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 15.20M | -4.43% | 84,578 | - |
| 486 | RADX | Radiopharm Theranostics Limited | 15.11M | -10.56% | 82,398 | 8.90M |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 14.28M | -2.18% | 132,552 | 7.11M |
| 488 | INAB | IN8bio, Inc. | 14.00M | 1.43% | 107,128 | - |
| 489 | NIKI | Niki BioSolutions, Inc. | 13.90M | 2.79% | 4,264 | - |
| 490 | HIND | Vyome Holdings, Inc. | 13.55M | 1.05% | 10,164 | 129.73K |
| 491 | AEON | AEON Biopharma, Inc. | 13.47M | -3.23% | 1,746,007 | - |
| 492 | PASG | Passage Bio, Inc. | 13.16M | -0.73% | 17,933 | - |
| 493 | TPST | Tempest Therapeutics, Inc. | 13.11M | -2.29% | 156,518 | - |
| 494 | DARE | Daré Bioscience, Inc. | 12.89M | 0.04% | 157,173 | 1.37M |
| 495 | PLUR | Pluri Inc. | 12.78M | 2.48% | 6,045 | 1.02M |
| 496 | BLRX | BioLineRx Ltd. | 12.71M | -2.11% | 20,258 | 1.39M |
| 497 | GDTC | CytoMed Therapeutics Limited | 12.05M | 9.78% | 68,329 | 609.73K |
| 498 | LTRN | Lantern Pharma Inc. | 12.02M | 9.30% | 276,170 | - |
| 499 | CNSY | Cerenome, Inc. | 11.84M | -2.50% | 222,893 | 4.20M |
| 500 | VTGN | Vistagen Therapeutics, Inc. | 11.68M | -6.33% | 1,921,842 | 2.50M |